ELEVATE 2 is no longer enrolling patients.

The ELEVATE 2 Study aimed to help researchers understand if rodatristat ethyl, an investigative oral medicine, is safe and effective when used with a patient’s usual medicines for the treatment of their PAH. This study is no longer enrolling patients.

Watch this video to learn more about rodatristat ethyl.

PULMONARY ARTERIAL HYPERTENSION

A rare disease that causes high blood pressure in the lungs and weakness in the heart.

Learn More

ELEVATE
STUDIES

Clinical research studies for adults diagnosed with pulmonary arterial hypertension (PAH).

Learn More

CLINICAL
RESEARCH

Learn more about clinical research.

Learn More